Fundraising Fox

Elysium Therapeutics

Danville, US · Founded 2013 · Delaware corporation

Biotech

Founders & leadership

KL
Kathy LaPorteNamed on SEC filing
AG
Alex Gregory SturmerNamed on SEC filing
BR
Bob RappaportNamed on SEC filing
TE
Thomas E. JenkinsNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$4M disclosed across 4 rounds · 2017–2022

▶$2.2MraisedOct 2022 · 30 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alex Gregory SturmerExecutive Officer, Director
  • Thomas JenkinsDirector
  • James HackworthDirector
  • Bob RappaportDirector
  • Kathy LaPorteDirector
  • Carey NgDirector
Offering amount
$9.1M
Amount sold
$2.2M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$215KraisedMar 2019 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kathy LaPorteDirector
  • Alex Gregory SturmerExecutive Officer, Director
  • Bob RappaportDirector
  • Thomas E. JenkinsExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$215K
Minimum investment
$1
First sale
Mar 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$932KraisedSep 2018 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kathy LaPorteDirector
  • Alex Gregory SturmerExecutive Officer, Director
  • Thomas E. JenkinsExecutive Officer, Director
  • Bob RappaportDirector
Offering amount
$2.3M
Amount sold
$932K
Minimum investment
$1
First sale
Sep 2018
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$651.8KraisedDec 2017 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kathy LaPorteDirector
  • Alex Gregory SturmerExecutive Officer, Director
  • Bob RappaportDirector
  • Thomas E. JenkinsExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$651.8K
Minimum investment
$1
Proceeds to insiders
$40K
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Elysium Therapeutics raised?
Elysium Therapeutics has disclosed $4M raised across 4 rounds.
Where is Elysium Therapeutics headquartered?
Elysium Therapeutics is headquartered in Danville, US.